Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The CD18 hypomorphic (CD18hypo) PL/J mouse model clinically resembling human psoriasis is characterized by reduced expression of the common chain of beta2 integrins (CD11/CD18) to only 2-16% of WT levels. Previously we found that this chronic psoriasiform skin inflammation also depends on the presence of CD4+ T cells. Herein we investigated the role of macrophages in this CD18hypo mouse model. Activated macrophages were significantly increased in lesional skin as well as in inflamed skin draining lymph nodes (DLNs) of affected CD18hypo mice and were identified as being an important source of TNF-alpha in vivo. Both depletion of macrophages and neutralization of TNF-alpha resulted in a significant alleviation of psoriasiform skin inflammation. As monocyte chemotactic protein 1 was enhanced in lesional skin of affected CD18hypo mice, we intradermally injected recombinant murine monocyte chemotactic protein-1 (rJE/MCP-1) alone or in combination with rTNF-alpha into the skin of healthy CD18hypo mice. Only simultaneous injection of rJE/MCP-1 and rTNF-alpha, but neither substance alone, resulted in the induction of psoriasiform skin inflammation around the injection sites with recruitment and activation of macrophages. Collectively, our data suggest that maintenance of psoriasiform skin inflammation critically depends on efficient recruitment and activation of macrophages with sufficient release of TNF-alpha.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrins: A family of cell surface receptors
HYNES, R. (1987) · Cell · doi:10.1016/0092-8674(87)90233-9 · Cited by 4,249 · cited 1×
“These integrins (CD11/CD18) are leukocyte adhesion molecules exclusively expressed on hemopoietic cells and are responsible for cell-cell contacts in a variety of inflammatory interactions (23).”
Leukocyte-endothelial adhesion molecules
Carlos, T., & Harlan, J. (1994) · Blood · doi:10.1182/blood.v84.7.2068.2068 · Cited by 2,701 · cited 1×
“These heterodimeric molecules interact with more than 20 known ligands, the most prominent of which belong to the ICAM family (24).”
Rooijen, N. V., & Sanders, A. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90012-4 · Cited by 1,779
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Etanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response
Sunderkötter, C., Nikolic, T., Dillon, M. J., van Rooijen, N., Stehling, M., Drevets, D. A., & Leenen, P. J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4410 · Cited by 1,124 · cited 1×
“A recent report further indicated that MCP-1 binds to the chemokine receptor CCR2, which was demonstrated to be expressed on peripheral blood monocytes from patients with psoriasis (42) and also on a subtype of murine monocytes principally involved in inflammation (38).”
Lu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017 · cited 2×
“Since MCP-1 expression is high at the epidermal/dermal junction in human plaque psoriasis and MCP-1 has strong macrophage-recruiting properties (3, 40), we next investigated MCP-1 expression and its function in our mouse model in more detail.”
Schön, M. P., & Boehncke, W.-H. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041320 · Cited by 955
Sano, S., Chan, K. S., Carbajal, S., Clifford, J., Peavey, M., Kiguchi, K., Itami, S., Nickoloff, B. J., & DiGiovanni, J. (2005) · Nature Medicine · doi:10.1038/nm1162 · Cited by 752 · cited 2×
“Most of these, however, reveal only a single or a few aspects resembling human psoriasis (11–14).”
Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins
Zenz, R., Eferl, R., Kenner, L., Florin, L., Hummerich, L., Mehic, D., Scheuch, H., Angel, P., Tschachler, E., & Wagner, E. F. (2005) · Nature · doi:10.1038/nature03963 · Cited by 599 · cited 2×
“Most of these, however, reveal only a single or a few aspects resembling human psoriasis (11–14).”
Treatment of Chronic Plaque Psoriasis by Selective Targeting of Memory Effector T Lymphocytes
Ellis, C. N., & Krueger, G. G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450403 · Cited by 582 · cited 1×
“This view on effector/memory T cells in the immunopathogenesis of human psoriasis is shared by several reports (18, 56).”
Anti-TNF-α therapies: the next generation
Palladino, M. A., Bahjat, F. R., Theodorakis, E. A., & Moldawer, L. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1175 · Cited by 576
Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
Nickoloff, B. J., & Nestle, F. O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422147 · Cited by 544 · cited 4×
“Previously, introduction of an insertion mutation in the murine CD18 gene — resulting in a duplication of exons 2 and 3 — yielded a mouse model with a severe reduction of CD18 expression, at levels only 2–16% of WT (15).”
InfluentialTNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2
Pasparakis, M., Courtois, G., Hafner, M., Schmidt-Supprian, M., Nenci, A., Toksoy, A., Krampert, M., Goebeler, M., Gillitzer, R., Israel, A., et al. (2002) · Nature · doi:10.1038/nature00820 · Cited by 470 · cited 2×
“Immunohistochemistry was performed using a previously described protocol (13).”
T Cells Involved in Psoriasis Vulgaris Belong to the Th1 Subset
Schlaak, J. F., Buslau, M., Jochum, W., Hermann, E., Girndt, M., Gallati, H., Büschenfelde, K.-H. M. Z., & Fleischer, B. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371752 · Cited by 455
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease
Ghoreschi, K., Thomas, P., Breit, S., Dugas, M., Mailhammer, R., van Eden, W., van der Zee, R., Biedermann, T., Prinz, J., Mack, M., et al. (2003) · Nature Medicine · doi:10.1038/nm804 · Cited by 453 · cited 2×
“…of directly targeting TNF-a in the treat-ment of human psoriasis (6, 9), therapies that most likely impair macrophage function by diminishing the production and release of TNF-a , such as IL-4 (50), IL-11 (51), and anti–IL-12 (52), have previously been reported to improve this medical condition.”
Gene for Familial Psoriasis Susceptibility Mapped to the Distal End of Human Chromosome 17q
Tomfohrde, J., Silverman, A., Barnes, R., Fernandez-Vina, M. A., Young, M., Lory, D., Morris, L., Wuepper, K. D., Stastny, P., Menter, A., et al. (1994) · Science · doi:10.1126/science.8178173 · Cited by 426 · cited 1×
“Linkage analysis of psoriasis families has identified a region on chromosome 17, including — among other loci — the ICAM-2 locus, an important ligand of the CD11/CD18 heterodimers (29).”
TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques
Gottlieb, A. B., Chamian, F., Masud, S., Cardinale, I., Abello, M. V., Lowes, M. A., Chen, F., Magliocco, M., & Krueger, J. G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2721 · Cited by 372 · cited 1×
“Etanercept is well suited for the study of the effect of blocking TNF-a function in the regulation of cellular events during the development of psoriasis, as its action is due to neutralization of soluble TNF-a and not to the depletion of cells with membrane-bound TNF-a (10).”
The Cytokine Network in Psoriasis
Nickoloff, B. J. (1991) · Archives of Dermatology · doi:10.1001/archderm.127.6.871 · Cited by 344
LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-α
Xaus, J., Comalada, M., Valledor, A. F., Lloberas, J., López-Soriano, F., Argilés, J. M., Bogdan, C., & Celada, A. (2000) · Blood · doi:10.1182/blood.v95.12.3823 · Cited by 331
Kauffman, C. L., Aria, N., Toichi, E., McCormick, T. S., Cooper, K. D., Gottlieb, A. B., Everitt, D. E., Frederick, B., Zhu, Y., Graham, M. A., et al. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23448.x · Cited by 279 · cited 1×
“…of directly targeting TNF-a in the treat-ment of human psoriasis (6, 9), therapies that most likely impair macrophage function by diminishing the production and release of TNF-a , such as IL-4 (50), IL-11 (51), and anti–IL-12 (52), have previously been reported to improve this medical condition.”
Van Rooijen, N., Kors, N., Ende, M. V. D., & Dijkstra, C. D. (1990) · Cell and Tissue Research · doi:10.1007/bf00318625 · Cited by 262
Gene targeting yields a CD18-mutant mouse for study of inflammation.
Wilson, R. W., Ballantyne, C. M., Smith, C. W., Montgomery, C., Bradley, A., O'Brien, W. E., & Beaudet, A. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1571 · Cited by 236
Latent TGFβ1 overexpression in keratinocytes results in a severe psoriasis‐like skin disorder
Li, A. G., Wang, D., Feng, X., & Wang, X. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600183 · Cited by 224
Stratis, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27179 · Cited by 222
Trepicchio, W. L., Ozawa, M., Walters, I. B., Kikuchi, T., Gilleaudeau, P., Bliss, J. L., Schwertschlag, U., Dorner, A. J., & Krueger, J. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6910 · Cited by 217 · cited 2×
“…of directly targeting TNF-a in the treat-ment of human psoriasis (6, 9), therapies that most likely impair macrophage function by diminishing the production and release of TNF-a , such as IL-4 (50), IL-11 (51), and anti–IL-12 (52), have previously been reported to improve this medical condition.”
The Immunologic and Genetic Basis of Psoriasis
Nickoloff, B. J. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.9.1104 · Cited by 212
Murine psoriasis-like disorder induced by naive CD4+ T cells
SchÖn, M. P., Detmar, M., & Parker, C. M. (1997) · Nature Medicine · doi:10.1038/nm0297-183 · Cited by 167
KRAAL, G., REP, M., & JANSE, M. (1987) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1987.tb02301.x · Cited by 165 · cited 1×
“…Fluor 488–conjugated Rat Anti-Mouse F4/80 (clone CI: A3-1, CALTAG Laboratories; Invitrogen) for the detection of mature tissue macrophages, and MOMA-2 (clone MOMA-2; Serotec) for the specific detection of the less mature monocyte/macrophage population in lymph nodes, as described previously (61).”
“In Vivo” Depletion of Macrophages by Liposome-Mediated “Suicide”
Rooijen, N. V., & Kesteren-Hendrikx, E. V. (2003) · Methods in Enzymology · doi:10.1016/s0076-6879(03)73001-8 · Cited by 164
Nakamura, K., Williams, I. R., & Kupper, T. S. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12324061 · Cited by 163 · cited 1×
“Our data is in line with MCP-1 transgenic mice, in which MCP-1 overexpression led to a marked increase in monocytes/macrophages in lung and skin but did not cause clinically relevant inflammatory phenotypes (44, 45).”
Ackermann, L., & Harvima, I. T. (1998) · Archives of Dermatological Research · doi:10.1007/s004030050317 · Cited by 162
Drevets, D. A., Dillon, M. J., Schawang, J. S., van Rooijen, N., Ehrchen, J., Sunderkötter, C., & Leenen, P. J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4418 · Cited by 160 · cited 2×
“Thus interaction of MCP-1 and CCR2 is likely to be of importance for monocyte/ macrophage trafficking in inflammatory skin disorders (43).”
MCP-1 mRNA Expression in Basal Keratinocytes of Psoriatic Lesions
Gillitzer, R., Wolff, K., Castillo‐Tong, D. C., Mueller, C., Yoshimura, T., Hartmann, A., Stingl, G., & Berger, R. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12363613 · Cited by 150 · cited 5×
“Since MCP-1 expression is high at the epidermal/dermal junction in human plaque psoriasis and MCP-1 has strong macrophage-recruiting properties (3, 40), we next investigated MCP-1 expression and its function in our mouse model in more detail.”
Influentialvan de Kerkhof, P. C., & Zeeuwen-Franssen, M. E. J. (2001) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200102030-00005 · Cited by 149
Grewal, I. S., Rutledge, B. J., Fiorillo, J. A., Gu, L., Gladue, R. P., Flavell, R. A., & Rollins, B. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.401 · Cited by 146
Macrophages and Dendritic Cells Constitute a Major Subpopulation of Cells in the Mouse Dermis
Dupasquier, M., Stoitzner, P., van Oudenaren, A., Romani, N., & Leenen, P. J. M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23427.x · Cited by 116 · cited 2×
“The specificity of clodronate liposomes for the depletion of phagocytic cells has repeatedly been shown (37–39).”
Miller, R. A. (1982) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1982.tb02070.x · Cited by 109
Anti-CD4 monoclonal antibody therapy in severe psoriasis
Morel, P., Revillard, J., Nicolas, J., Wijdenes, J., Rizova, H., & Thivolet, J. (1992) · Journal of Autoimmunity · doi:10.1016/0896-8411(92)90006-c · Cited by 106 · cited 1×
“This is analogous to affected skin of psoriasis patients in which CD4 + T cells prevail (22).”
The role of LFA-1/ICAM-1 interactions during murine T lymphocyte development
Fine, J. S., & Kruisbeek, A. M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.9.2852 · Cited by 104
Vestergaard, C., Just, H., Baumgartner Nielsen, J., Thestrup-Pedersen, K., & Deleuran, M. (2004) · Acta Dermato-Venereologica · doi:10.1080/00015550410034444 · Cited by 103 · cited 2×
“A recent report further indicated that MCP-1 binds to the chemokine receptor CCR2, which was demonstrated to be expressed on peripheral blood monocytes from patients with psoriasis (42) and also on a subtype of murine monocytes principally involved in inflammation (38).”
Shinozaki, M., Hirahashi, J., Lebedeva, T., Liew, F. Y., Salant, D. J., Maron, R., & Kelley, V. R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14574 · Cited by 100 · cited 2×
“A capillary real-time thermocycler (LightCycler; Roche Diagnostics) was used to perform quantitative PCR as described previously (62). cDNA derived from lesional skin of 3 additional affected CD18 hypo mice or normal skin of CD18 WT mice was pooled to perform semiquantitative RT-PCR.”
Wakefield, P. E., James, W. D., Samlaska, C. P., & Meltzer, M. S. (1991) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(91)70102-8 · Cited by 100 · cited 2×
“7, 8).”
Resolution of cutaneous inflammation after local elimination of macrophages
Thepen, T., van Vuuren, A. J. H., Kiekens, R. C. M., Damen, C. A., Vooijs, W. C., & van de Winkel, J. G. J. (2000) · Nature Biotechnology · doi:10.1038/71908 · Cited by 98 · cited 2×
“In order to gain more insight into the role of macrophages in various models of inflammation, several approaches have been used to reduce macrophage activity, including blockade of secreted cytokines (32), and downregulation of macrophage activity (33) using Ricin A-coupled antibodies directed against the high-affinit…”
Nickoloff, B. J. (2000) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2000.00006.x · Cited by 87
A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice.
Bullard, D. C., Scharffetter-Kochanek, K., McArthur, M. J., Chosay, J. G., McBride, M. E., Montgomery, C. A., & Beaudet, A. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2116 · Cited by 87 · cited 4×
“Backcross analysis suggests that, in addition to the CD18 hypo mutation, a small number of other genes determine susceptibility to the disease (16).”
InfluentialImmunopathogenesis of Psoriasis
Ozawa, M., & Aiba, S. (2004) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010043343868 · Cited by 77
β2 integrins are required for skin homing of primed T cells but not for priming naive T cells
Grabbe, S., Varga, G., Beissert, S., Steinert, M., Pendl, G., Seeliger, S., Bloch, W., Peters, T., Schwarz, T., Sunderkötter, C., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci11703 · Cited by 77
Djemadji-Oudjiel, N., Goerdt, S., Kodelja, V., Schmuth, M., & Orfanos, C. E. (1996) · Archives of Dermatological Research · doi:10.1007/bf02505293 · Cited by 74
Shuster, S. (1972) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1972.tb05103.x · Cited by 63 · cited 1×
“In severely affected mice reversible alopecia was observed, a feature which may only rarely, if at all, occur in human psoriasis (17).”
Keratinocytes regain momentum as instigators of cutaneous inflammation
Nickoloff, B. J. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.01.001 · Cited by 61 · cited 1×
“It is possible that psoriasis is also pathogenetically not a homogeneous entity, and while some cases may be caused by T cell–dependent activation of macrophages, others may occur via T cell–independent mechanisms of macrophage activation (58).”
Kess, D., Peters, T., Zamek, J., Wickenhauser, C., Tawadros, S., Loser, K., Varga, G., Grabbe, S., Nischt, R., Sunderkötter, C., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5697 · Cited by 58
Epithelium-lining macrophages in psoriasis
van den Oord, J. J., & Wolf‐Peeters, C. D. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb13104.x · Cited by 56
Genčík, M., Meller, S., Borgmann, S., Sitter, T., Vieira-Saecker, A. M. M., Fricke, H., & Epplen, J. T. (2000) · Clinical Immunology · doi:10.1006/clim.1999.4811 · Cited by 40
Infliximab for psoriasis and psoriatic arthritis.
Antoni, C., & Manger, B. (2002) · PubMed · Cited by 39
Skin manifestations in congenital deficiency of leucocyte-adherence glycoproteins (CDLG)
van de Kerkhof, P. C. M., & Weemaes, C. M. R. (1990) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1990.tb06301.x · Cited by 36
Novel SNPs in the CD18 gene validate the association with MPO-ANCA + vasculitis
Meller, S., Jagiello, P., Borgmann, S., Fricke, H., Epplen, J. T., & Genčík, M. (2001) · Genes and Immunity · doi:10.1038/sj.gene.6363781 · Cited by 35 · cited 1×
“Furthermore, polymorphisms in the CD18 gene have been found that predispose to autoimmune diseases (30, 31).”
Feldman, S. R., Ravis, S. M., Fleischer, A. B., McMichael, A. J., Jones, E., Kaplan, R. J., Shavin, J. S., Weiss, J., Bartruff, K. J., Levin, D. L., et al. (2001) · Journal of Cutaneous Medicine and Surgery · doi:10.1007/s10227-001-0005-1 · Cited by 34
T cell-macrophage cognate interaction in the activation of macrophage effector function by Th2 cells
Stout, R. D., & Suttles, J. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5330 · Cited by 23 · cited 1×
“Even though CD4 + T cells have earlier been shown to activate macrophages by enhanced IFN-g release (46), our data suggest that once macrophages are activated directly by proinflammatory cytokines such as TNF-a , they have the capacity to induce the psoriasiform inflammatory skin disease…”
Psoriasis-like Skin Disease and Arthritis Caused by Inducible Epidermal Deletion of Jun Proteins
THIERS, B. H. (2006) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70032-7 · Cited by 21
Kurimoto, I., van Rooijen, N., Dijkstra, C. D., & Jw, S. (1994) · PubMed Central · Cited by 17
Djemadji-Oudjiel, N., Goerdt, S., Kodelja, V., et al. (1996) · Archives of Dermatological Research · doi:10.1007/s004030050137 · Cited by 14
Shinozaki, M., Hirahashi, J., Lebedeva, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214574 · Cited by 12
Anti-CD11a prevents deletion of self-reactive T cells in neonatal C57BR mice.
Quddus, J., Kaplan, A. M., & Richardson, B. C. (1994) · PubMed Central · Cited by 10
β2 integrins are required for skin homing of primed T cells but not for priming naive T cells
Grabbe, S., Varga, G., Beissert, S., Steinert, M., Pendl, G. G., Seeliger, S., Bloch, W., Peters, T., Schwarz, T., Sunderkötter, C. H., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200211703 · Cited by 3
Warrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
Cited by
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
van der Fits, L., Mourits, S., Voerman, J. S. A., Kant, M., Boon, L., Laman, J. D., Cornelissen, F., Mus, A.-M., Florencia, E., Prens, E. P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802999 · Cited by 2,176
“An essential role for macrophages was established recently in two different mouse models for psoriasis-like skin inflammation, that is, the CD18 hypomorphic PJ/L mice, and mice with an epidermis-specific deletion of IKK2 (49, 50). pDC play an essential role in the conversion of nonlesional to lesional psoriasis skin i…”
BackgroundPathogenesis and clinical features of psoriasis
Griffiths, C. E., & Barker, J. N. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61128-3 · Cited by 2,158
Sindrilaru, A., Peters, T., Wieschalka, S., Baican, C., Baican, A., Peter, H., Hainzl, A., Schatz, S., Qi, Y., Schlecht, A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44490 · Cited by 1,100
Mechanisms regulating skin immunity and inflammation
Pasparakis, M., Haase, I., & Nestle, F. O. (2014) · Nature Reviews Immunology · doi:10.1038/nri3646 · Cited by 886
Metadata
- Authors
- Wang, H.
- Affiliations
- Universität Ulm (DE)
- Corresponding author
- Wang, H.
- ORCID
- Wang, H.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-08-01
- Volume
- 116
- Issue
- 8
- Pages
- 2105-2114
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1523400
- OpenAlex
- W2136157736
- Cited by
- 276
- References
- 66
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 20 · 2023: 6 · 2022: 15 · 2021: 9 · 2020: 11 · 2019: 12 · 2018: 11 · 2017: 11 · 2016: 9 · 2015: 13 · 2014: 13 · 2013: 16 · 2012: 9
- FWCI
- 8.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SU 195/3-1, SFB 497)
- Universität Ulm
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
- Keywords
- psoriasis, macrophages, beta2 integrins, CD4+ T cells, TNF-α, MCP-1, macrophage recruitment, skin inflammation, macrophage depletion, draining lymph nodes
- MeSH terms
- Animals, Disease Models, Animal, Inflammation, Macrophage Activation, Mice, Inbred Strains, Mutation, Phenotype, Psoriasis, Recombinant Proteins, RNA, Messenger, T-Lymphocytes, CD18 Antigens, CD11 Antigens, Chemokine CCL2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.